FDAnews
www.fdanews.com/articles/138067-merck-gets-marketing-approval-for-gardasil-zolinza-cubicin-in-japan

Merck Gets Marketing Approval for Gardasil, Zolinza, Cubicin in Japan

July 1, 2011
Healthcare giant Merck & Co. Friday said its human papillomavirus vaccine gardasil, anti-cancer drug zolinza and bacterial infections treatment cubicin have been approved by the Japanese health ministry for use in the country.
RTT News